Internal Medicine, Hematology & Oncology · Kingwood, TX
NPI
1427081710
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
22751 Professional Dr Ste 140
Kingwood, TX, 77339
Phone (281) 975-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$876K
70,833 services
Medicare patients, 2024
1,138
Average age 74
Drug cost, 2024
$4.6M
1,171 prescriptions
Company payments, 2025
$6,885
From 59 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David P Ellent was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 21,930 times for 17 patients. In total David P Ellent billed 70,833 services in 213 codes, and Medicare paid $876K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 21,930 | 17 | $0.27 | $6,008 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 3,821 | 341 | $34.25 | $131K |
| 85025 Blood Count | Office | 1,756 | 579 | $7.53 | $13K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,750 | 14 | $0.09 | $153 |
| 80053 Clinical Chemistry | Office | 1,721 | 585 | $10.27 | $18K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 883 | 178 | $34.27 | $30K |
| 84466 Clinical Chemistry | Office | 747 | 389 | $12.39 | $9,257 |
| 82728 Clinical Chemistry | Office | 745 | 388 | $13.24 | $9,867 |
| 36415 Venipuncture Blood Collection | Office | 642 | 371 | $8.62 | $5,537 |
| 83540 Clinical Chemistry | Office | 620 | 355 | $6.29 | $3,902 |
| 82607 Clinical Chemistry | Office | 539 | 354 | $14.63 | $7,884 |
| 82746 Clinical Chemistry | Office | 530 | 345 | $14.27 | $7,563 |
| 96367 Intravenous Infusion, Hydration | Office | 515 | 33 | $22.20 | $11K |
| 99214 Office E&M - Established | Office | 400 | 159 | $94.14 | $38K |
| 87653 Infectious Agent Detection by DNA/RNA | Office | 398 | 341 | $34.07 | $14K |
By year: 2022 $1.1M for 111,698 services; 2023 $995K for 72,575 services; 2024 $876K for 70,833 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 3,821 | 341 | $34.25 | $131K |
| 85025 Blood Count | 1,756 | 579 | $7.53 | $13K |
| 80053 Clinical Chemistry | 1,721 | 585 | $10.27 | $18K |
| 87481 Infectious Agent Detection by DNA/RNA | 883 | 178 | $34.27 | $30K |
| 84466 Clinical Chemistry | 747 | 389 | $12.39 | $9,257 |
| 82728 Clinical Chemistry | 745 | 388 | $13.24 | $9,867 |
| 36415 Venipuncture Blood Collection | 642 | 371 | $8.62 | $5,537 |
| 83540 Clinical Chemistry | 620 | 355 | $6.29 | $3,902 |
| 82607 Clinical Chemistry | 539 | 354 | $14.63 | $7,884 |
| 82746 Clinical Chemistry | 530 | 345 | $14.27 | $7,563 |
Medicare prescription drug claims, 2024
In 2024, the drug David P Ellent prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 85 prescriptions and refills. In total David P Ellent wrote 1,171 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 85 | 85 | 21 | $3,563 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 76 | 89 | Under 11 | $372K |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 70 | 70 | 68 | $16K |
| Anastrozole Generic | 63 | 132 | 18 | $1,328 |
| Fentanyl Generic | 46 | 46 | Under 11 | $5,622 |
| Opdivo Nivolumab | 45 | 45 | Under 11 | $679K |
| Lupron Depot Leuprolide Acetate | 38 | 70 | Under 11 | $134K |
| Procrit Epoetin Alfa | 35 | 39 | 13 | $143K |
| Nyvepria Pegfilgrastim-Apgf | 33 | 33 | Under 11 | $124K |
| Ondansetron Hcl Generic | 32 | 32 | 18 | $717 |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 31 | 31 | 31 | $9,881 |
| Keytruda Pembrolizumab | 29 | 29 | Under 11 | $368K |
| Dexamethasone Generic | 26 | 26 | Under 11 | $421 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 25 | 25 | 25 | $1,768 |
| Hydroxyurea Generic | 20 | 47 | Under 11 | $488 |
Brand drugs: 652 claims; generic drugs: 519 claims; opioid claims: 159.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David P Ellent $6,885 ($6,885 in general payments such as food, travel and fees) from 59 companies. The largest payer was OnMark, Inc. with $3,070.
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 10 | $3,070 |
| Janssen Biotech, Inc. JNJ | 12 | $327 |
| US Oncology Corporate, Inc. | 1 | $233 |
| Merck Sharp & Dohme LLC MRK | 10 | $208 |
| Daiichi Sankyo Inc. 4568.T | 9 | $199 |
| Tempus AI, Inc TEM | 9 | $172 |
| Abbvie Inc. ABBV | 8 | $159 |
| Pharmacosmos Therapeutics Inc. | 4 | $110 |
| Genzyme Corporation SNY | 4 | $109 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.